| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A novel TB vaccine; towards a strategy based on our understanding of BCG failure
|
Agger, E.M.
|
|
2002
|
21 |
1-2 |
p. 7-14
8 p.
|
article
|
| 2 |
Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase
|
Yoshikawa, Tomoki
|
|
2002
|
21 |
1-2 |
p. 60-66
7 p.
|
article
|
| 3 |
Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children
|
Hallander, H.O
|
|
2002
|
21 |
1-2 |
p. 138-145
8 p.
|
article
|
| 4 |
Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus
|
Bastos, Reginaldo G
|
|
2002
|
21 |
1-2 |
p. 21-29
9 p.
|
article
|
| 5 |
CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein
|
Ioannou, X.P
|
|
2002
|
21 |
1-2 |
p. 127-137
11 p.
|
article
|
| 6 |
Detection of residual pertussis toxin in vaccines using a modified ribosylation assay
|
Yuen, Chun-Ting
|
|
2002
|
21 |
1-2 |
p. 44-52
9 p.
|
article
|
| 7 |
Editorial Board/Aims and Scope
|
|
|
2002
|
21 |
1-2 |
p. IFC-
1 p.
|
article
|
| 8 |
Emergency response vaccines—a challenge for the public sector and the vaccine industry
|
Milstien, Julie
|
|
2002
|
21 |
1-2 |
p. 146-154
9 p.
|
article
|
| 9 |
Evaluation of the immunocontraceptive potential of Escherichia coli expressed recombinant non-human primate zona pellucida glycoproteins in homologous animal model
|
Govind, Chhabi K
|
|
2002
|
21 |
1-2 |
p. 78-88
11 p.
|
article
|
| 10 |
Hepatitis B vaccination: how to reach risk groups
|
François, Guido
|
|
2002
|
21 |
1-2 |
p. 1-4
4 p.
|
article
|
| 11 |
Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya
|
Hanke, T
|
|
2002
|
21 |
1-2 |
p. 108-114
7 p.
|
article
|
| 12 |
Low mortality after mild measles infection compared to uninfected children in rural west Africa
|
Aaby, Peter
|
|
2002
|
21 |
1-2 |
p. 120-126
7 p.
|
article
|
| 13 |
Occurrence of adverse events following inadvertent administration of childhood vaccines
|
Derrough, Tarik F
|
|
2002
|
21 |
1-2 |
p. 53-59
7 p.
|
article
|
| 14 |
Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations
|
Konishi, Eiji
|
|
2002
|
21 |
1-2 |
p. 98-107
10 p.
|
article
|
| 15 |
Recombinant vaccinia virus (WR strain) may not be suitable for ex vivo stimulation
|
Xin, Ke-Qin
|
|
2002
|
21 |
1-2 |
p. 5-6
2 p.
|
article
|
| 16 |
Routine vaccinations and child survival in a war situation with high mortality: effect of gender
|
Aaby, Peter
|
|
2002
|
21 |
1-2 |
p. 15-20
6 p.
|
article
|
| 17 |
Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis
|
Santos, Wania Renata
|
|
2002
|
21 |
1-2 |
p. 30-43
14 p.
|
article
|
| 18 |
Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres
|
Gutierro, I
|
|
2002
|
21 |
1-2 |
p. 67-77
11 p.
|
article
|
| 19 |
Synthetic AIDS vaccine by targeting HIV receptor
|
Wang, Chang Yi
|
|
2002
|
21 |
1-2 |
p. 89-97
9 p.
|
article
|
| 20 |
The assessment of OPV vaccines by the monkey neurovirulence test: why and how to qualify the experts in histology of central nervous system
|
Poirier, Bertrand
|
|
2002
|
21 |
1-2 |
p. 115-119
5 p.
|
article
|
Journal description